EI
RBOT

Ellevest Inc’s Vicarious Surgical RBOT Stock Holding History

Ellevest Inc’s Portfolio RBOT Stock Details RBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-102
Closed -$6.92K – 1326
2023
Q1 		$6.92K Buy
102
+3
+3% +$233 ﹤0.01% 1130
2022
Q4 		$6K Buy
+99
New +$9.2K ﹤0.01% 1147

Other funds holding RBOT

VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
DP
DDD Partners Bellevue, Washington $1.45B AUM 9.14% 1-Year Est. Return
AMH
Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
HVCM
Hel Ved Capital Management Central, Hong Kong $844M AUM 191.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ellevest Inc's RBOT Position: Q2 2023 in Review

Ellevest Inc sold out of Vicarious Surgical (RBOT) in Q2 2023, closing a stake of 102 shares — an estimated $6.92K sold.

Ellevest Inc first reported a position in RBOT in Q4 2022 and held it in 2 quarters. The position peaked at $6.92K in Q1 2023. 74 funds tracked by Wall St. Rank hold RBOT as of Q2 2023.

  • Ellevest Inc reported no remaining Vicarious Surgical position as of Q2 2023 after selling out during the quarter.
  • Ellevest Inc sold 102 Vicarious Surgical shares in Q2 2023, an estimated $6.92K.
  • Ellevest Inc first reported a position in Vicarious Surgical in Q4 2022 and held it in 2 quarters.
  • Ellevest Inc's Vicarious Surgical position peaked at $6.92K in Q1 2023.
  • 74 funds tracked by Wall St. Rank held Vicarious Surgical as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.